Development of specific assays for assessing each step of CMG assembly, testing protein-protein interactions, and the success of high-yield purification of the CMG combined with high-throughput drug screenings will provide innovative means to identify small molecules targeting CMG assembly and helicase activity, ultimately contributing to development of novel and effective cure for human cancers. This evidence concerns the gene CASK and cancer.